Business Context and Reporting Period
Company: Red Robin Gourmet Burgers, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: April 13, 2020
Event Date: April 10, 2020
Context: The filing reports the entry into and termination of a material definitive agreement regarding the Company's Rights Agreement, as well as updates to equity compensation plan availability.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses on corporate governance and equity plan administration.
Material Changes
- Termination of Rights Agreement: On April 10, 2020, the Company entered into Amendment No. 1 to its Rights Agreement (dated June 4, 2019). This amendment accelerated the expiration of the Rights from June 2, 2020, to April 13, 2020, effectively terminating the agreement.
- Equity Plan Availability: Between March 30, 2020, and April 13, 2020, the number of shares remaining available for issuance under the 2017 Performance Incentive Plan decreased significantly from approximately 769,155 to 273,242 due to new equity grants.
Outlook, Risks, and Unusual Items
Equity Compensation Status (as of April 13, 2020):
- Stock Options Outstanding: 487,485 (Weighted-average exercise price: $36.26; Weighted-average remaining term: 7.52 years).
- Full Value Awards Outstanding: 967,549 (Includes 645,670 shares underlying unvested PSUs assuming maximum performance and 321,879 shares underlying unvested RSUs).
- Shares Available for Issuance: 273,242 under the 2017 Performance Incentive Plan.
Unusual Items: The filing notes that no stock appreciation rights were outstanding as of the report date.
Investor Verification Checklist
- Verify the terms of Amendment No. 1 to the Rights Agreement (Exhibit 4.1) to confirm the complete termination of the poison pill provision.
- Confirm the impact of the recent equity grants on the remaining share pool available for future executive compensation.
- Review the weighted-average exercise price ($36.26) of outstanding options relative to the current market price to assess dilution potential.
- Note that the filing does not provide updated financial results; investors should refer to the most recent 10-Q or 10-K for financial performance.